New research from an international team of HIV/AIDS experts has reaffirmed the effectiveness of Truvada-the first and only medication approved by the FDA for HIV prevention. Led by Gladstone Investigator Robert Grant, MD, MPH and Peter Anderson, PharmD, at the University of Colorado, the research provides the first estimate of the drug concentration levels needed for Truvada to prevent the spread of HIV/AIDS-expanding our understanding of Truvada's potency and opening the door to new dosing strategies...
More...
More...